Inventor · disambiguated record
Mircea-Alexandru Mateescu
Also filed as: MATEESCU MIRCEA A · MATEESCU MIRCEA-ALEXANDRU
11 granted patents·23 pending applications·263 citations·filing 1993–2024
89Inventor score
Top patents by PatentIndex Score
34 records- 0181US5603956ACross-linked enzymatically controlled drug releaseLABOPHARM INC·Filed 1994·Granted Feb 18, 1997·70 cites·10 claims
- 0281US5456921AUse of cross-linked amylose as a matrix for the slow release of biologically active compoundsLABOPHARM INC·Filed 1994·Granted Oct 10, 1995·70 cites·29 claims
- 0376US2024315974A1Two speed monolithic system for controlled release of drugsMATRIPHARM INT INC·Filed 2024·Application pending·0 cites
- 0474US6419957B1Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agentsLABOPHARM INC·Filed 1999·Granted Jul 16, 2002·40 cites·6 claims
- 0574US5616343ACross-linked amylose as a binder/disintegrant in tabletsLABOPHARM INC·Filed 1993·Granted Apr 1, 1997·48 cites·20 claims
- 0674US2024293326A1Controlled release formulations for the treatment of malariaKARICI DIAGNOSTICS INC·Filed 2024·Application pending·0 cites
- 0772US2024293327A1Monolithic tablets based on carboxyl polymeric complexes for controlled drug releaseMATRIPHARM INT INC·Filed 2024·Application pending·0 cites
- 0872US2023270683A1Two speed monolithic system for controlled release of drugsMATRIPHARM INT INC·Filed 2023·Application pending·0 cites
- 0968US6284273B1Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compoundsFiled 1998·Granted Sep 4, 2001·33 cites·34 claims
- 1066US2020108017A1Two speed monolithic system for controlled release of drugsMATRIPHARM INT INC·Filed 2019·Application pending·0 cites
- 1165US2021401756A1Two speed monolithic system for controlled release of drugsMATRIPHARM INT INC·Filed 2021·Application pending·0 cites
- 1262US2017296470A1Two speed monolothic system for controlled release of drugsMATRIPHARM INC·Filed 2017·Application pending·0 cites
- 1362US2021338589A1Controlled release formulations for the treatment of malariaKARICI DIAGNOSTICS INC·Filed 2019·Application pending·0 cites
- 1460US2021244671A1Monolithic tablets based on carboxyl polymeric complexes for controlled drug releaseMATRIPHARM INT INC·Filed 2021·Application pending·0 cites
- 1557US6858646B2Neuroprotective composition and uses thereofUNIV QUEBEC MONTREAL·Filed 2001·Granted Feb 22, 2005·2 cites·19 claims
- 1652US2020054565A1Monolithic tablets based on carboxyl polymeric complexes for controlled drug releaseMATRIPHARM INT INC·Filed 2019·Application pending·0 cites
- 1749US2013338121A1Two speed monolithic system for controlled release of drugsCANH LE TIEN·Filed 2012·Application pending·0 cites
- 1849US2005084512A1Tridimensional biocompatible support structure for bioartificial organs and uses thereofFiled 2003·Application pending·0 cites
- 1945US2014005280A1Carboxymethyl starch and chitosan polyelectrolyte complexesASSAAD ELIAS·Filed 2012·Application pending·0 cites
- 2044US2017049705A1Monolithic tablets based on carboxyl polymeric complexes for controlled drug releaseMATRIPHARM INC·Filed 2015·Application pending·0 cites
- 2141US8722038B2Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthmaMONDOVI′ BRUNO·Filed 2008·Granted May 13, 2014·0 cites·8 claims
- 2241US2005226905A1Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protectionTIEN CANH L·Filed 2001·Application pending·0 cites
- 2340US2004235947A1Neuroprotective composition and uses thereofFiled 2004·Application pending·0 cites
- 2439US6780842B2Ceruloplasmin and an antioxidant composition comprising the same and their uses as neuroprotective agentWARNER LAMBERT CO·Filed 2001·Granted Aug 24, 2004·0 cites·12 claims
- 2537US2003166511A1Cardioprotective composition comprising ceruloplasmin and uses thereofGESTILAB INC·Filed 2001·Application pending·0 cites
- 2637US2007077305A1Biocompatible polymeric matrix and preparation thereofLE TIEN C·Filed 2005·Application pending·0 cites
- 2735US2002123525A1Cardioprotective composition and uses thereofGESTILAB INC·Filed 2001·Application pending·0 cites
- 2835US2013337062A1Gastro-resistant enzyme pharmaceutical compositionsAPTALIS PHARMA CANADA INC·Filed 2013·Application pending·0 cites
- 2934US12109217B2Bioactive agents included in functionalized starch having a single helix V-structureB ORGANIC FILMS CORP·Filed 2015·Granted Oct 8, 2024·0 cites·14 claims
- 3034US9220699B2Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredientsCANH LE TIEN·Filed 2013·Granted Dec 29, 2015·0 cites·17 claims
- 3130US2003054980A1Ceruloplasmin and uses thereof in neurodegenerative related conditionsFiled 2001·Application pending·0 cites
- 3226US2004115189A1Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthmaFiled 2001·Application pending·0 cites
- 3325US2008286253A1Composition Comprising Polymeric Material And Uses ThereofTRANSFERT PLUS SOC EN COMMANDI·Filed 2005·Application pending·0 cites
- 3424US9878020B2Oral enzyme compositions for intestinal deliveryMATEESCU MIRCEA-ALEXANDRU·Filed 2012·Granted Jan 30, 2018·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →